Shaanxi GangHuaBiotechnology

Shaanxi GangHua Biotechnology (HK) Limited (hereinafter referred to as the "company") is a Shaanxi province people's government approved establishment with a sole-source investment from Hong Kong and has independent rights to export and import (import and export enterprise code: ************4). Being headquartered in the Xi 'an high-tech development zone, our company is dedicated to the development, production and sales of nicotine and its derivative products using integrated cutting-edge technologies.
 
Our company focuses on the research and development of nicotine extraction, in particularly extraction of high purity nicotine. With the strong scientific research and technology support from the Hong Kong Baptist university, our company has a complete and well-qualified management system from the collection of raw tobacco leaves to the refining separation process for nicotine extraction. All our nicotine products conform to the requirements of the quality control standard for pharmaceutical production (API) (GMP), China tobacco industry YC/T *******0 standard or the United States pharmacopoeia commission USP*4 - NF*9 quality inspection standard.
 
Strong financial support, high quality, reasonable price, fast delivery and excellent service gain us good cooperative partnership with the famous university - Hong Kong Baptist University, various listed pharmaceutical and electronic chip companies, and other enterprises and institutions. At the same time, the products are also exported to many countries and regions, including the United States and the European Union and has set a good reputation in the market.
 
With our mission statement: "Promote the development of biotechnology to enhance human health service", our company aims to provide with our customers the best quality products and services, thereby promoting the continuous development of biotechnology in China.
 Shaanxi GangHua Biotechnology (HK) Limited (hereinafter referred to as the "company") is a Shaanxi province people's government approved establishment with a sole-source investment from Hong Kong and has independent rights to export and import (import and export enterprise code: ************4). Being headquartered in the Xi 'an high-tech development zone, our company is dedicated to the development, production and sales of nicotine and its derivative products using integrated cutting-edge technologies.
 
Our company focuses on the research and development of nicotine extraction, in particularly extraction of high purity nicotine. With the strong scientific research and technology support from the Hong Kong Baptist university, our company has a complete and well-qualified management system from the collection of raw tobacco leaves to the refining separation process for nicotine extraction. All our nicotine products conform to the requirements of the quality control standard for pharmaceutical production (API) (GMP), China tobacco industry YC/T *******0 standard or the United States pharmacopoeia commission USP*4 - NF*9 quality inspection standard.
 
Strong financial support, high quality, reasonable price, fast delivery and excellent service gain us good cooperative partnership with the famous university - Hong Kong Baptist University, various listed pharmaceutical and electronic chip companies, and other enterprises and institutions. At the same time, the products are also exported to many countries and regions, including the United States and the European Union and has set a good reputation in the market.
 
With our mission statement: "Promote the development of biotechnology to enhance human health service", our company aims to provide with our customers the best quality products and services, thereby promoting the continuous development of biotechnology in China.